Skip to main content

Table 4 Side-effect profiles of intravenous immunoglobulin infusion and therapeutic plasma exchange

From: Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome

Intravenous Immunoglobulin Infusion [2528]

Therapeutic Plasma Exchange [2123]

Mild (common)

Mild (common)

Fever

Fever

Facial flushing

Paresthesias due to hypocalcemia

Malaise

Hematoma at site of vascular access

Headache

Bleeding at site of vascular access

Chills

Muscle cramping due to hypocalcemia

Myalgia

Nausea

Fatigue

Vomiting

Dyspnea

Pallor

Back Pain

Diaphoresis

Abdominal pain

Hypotension

Nausea

Tachycardia

Vomiting

Urticaria

Diarrhea

Pruritis

Hypotension

Hypofibrinogenemia

Tachycardia

 

Urticaria

 

Pruritis

 

Pseudohyponatremia

 

Severe (uncommon)

Severe (uncommon)

Anaphylaxis

Anaphylaxis

Acute renal failure

Air embolism

Thromboembolic events

Arrhythmia

   Stroke

Hemolysis

   Myocardial infarction

Thrombocytopenia

   Deep venous thrombosis

Transfusion Related Acute Lung Injury

Aseptic meningitis

Pneumothorax due to central line

Progressive neurodegeneration

Hemothorax due to central line

Serum sickness

Tetany

Hemolysis

 

Neutropenia

 

Transfusion Related Acute Lung Injury

 

Uveitis

 

Leukocytoclastic vasculitis

 

Erythema multiforme